Meningitis Outbreak in Kent Could Spread as Students Travel Home for Easter
Health officials have warned that sporadic household clusters of meningitis could emerge in various parts of Britain over the coming month as university students travel home from Kent for the Easter holidays. This alert follows a significant outbreak in Canterbury, where cases have been steadily increasing.
Three Scenarios Modeled for Next Four Weeks
Dr Anjan Ghosh, Kent County Council's director of public health, addressed a briefing in Canterbury today, outlining three potential scenarios being examined over the next four weeks. He emphasized that this timeframe is critical as it represents the typical period for such outbreaks to subside.
The first scenario involves the outbreak remaining contained within Kent, with no further spread beyond the county's borders.
The second scenario, which Dr Ghosh described as most likely, involves students who have left Kent incubating the infection and developing cases elsewhere, leading to small household clusters outside the county. "They were incubating when they left, and then they become cases, and there are small household, sporadic clusters outside of Kent," he explained, while stressing these would be "containable."
The third scenario represents a worst-case situation where another cluster emerges outside Kent, though Dr Ghosh noted this is "highly unlikely."
Current Case Numbers and Response
The UK Health Security Agency (UKHSA) has reported that cases linked to the outbreak have reached 29, up from 27 previously. This includes 18 confirmed cases and 11 probable cases, all with connections to Kent. Thirteen of the confirmed cases involve the menB strain, and all affected individuals have required hospital admission.
Dr Ghosh sought to reassure the public by explaining that meningitis transmission differs significantly from diseases like COVID-19. "Meningitis is not spread the same way that Covid is spread, or measles is spread," he stated. "This requires protracted close contact in order for it to be spread, and that usually is in a household context or in a dormitory context. It requires close contact in the form of kissing, sharing utensils, things like that."
He urged anyone identified as a close contact by UKHSA to come forward for preventative antibiotics and emphasized there is "no reason for people to not be going about leading their normal lives."
Vaccination Efforts and Challenges
Today, hundreds of students queued at the University of Kent campus for vaccinations, with estimates suggesting around 700 staff and students were in line by 8:45 AM. This follows yesterday's situation where over 100 students were turned away due to staffing limitations.
Professor Robin May, chief scientific officer of UKHSA, acknowledged the staffing issue, telling Times Radio: "Yesterday, it was a staffing issue. To emphasise - we are not short of vaccine. Yesterday, demand exceeded the ability of staff to fulfil it within the time allocated."
Ed Waller, deputy chief executive of NHS Kent and Medway, confirmed there are "plenty" of vaccine doses available and noted that other clinics are operating with less congestion. He revealed that 6,500 vaccine doses have been delivered to Kent and Medway from national stock, with a request made today for an additional 5,000 doses.
As of 5 PM yesterday, 2,360 vaccinations have been administered, along with 9,840 doses of antibiotics to those affected by the outbreak.
Tragic Loss and Family Campaign
The human cost of the outbreak was highlighted by the death of 18-year-old Juliette Kenny on March 14, just one day after first showing symptoms. Her father Michael described her as "fit, healthy and strong" before her sudden illness, which began with vomiting and discolouration in her cheeks.
The Kenny family is now campaigning for teenagers and young people to receive routine access to the meningitis B vaccination. Juliette, described by her father as having a "beautifully positive energy," is one of two students who have died following the outbreak.
Expert Analysis and Future Concerns
Professor Paul Hunter from the University of East Anglia suggested the peak of the initial "superspreading event" at Club Chemistry in Canterbury may have passed, given the typical incubation period of two to ten days. However, he cautioned that secondary cases remain a possibility, though likely fewer than in the primary wave.
Professor Martin Maiden of Oxford University noted that the serogroup B meningococcal isolate from Kent represents a novel genotype within a known family of meningococci, predicted to be covered by available vaccines. He stated that previous experience suggests spread will likely be limited by the variant's invasive capacity, but emphasized the need for continued surveillance.
Professor May acknowledged that experts are still investigating whether the meningitis bug has become more transmissible in recent cases. When asked about future outbreaks, he responded: "Well obviously that's something we're very conscious of. We'll be mindful both of the possibility of this particular strain, for example, re-emerging in the future, but also general principles that we'll learn about the bacteria."
The UKHSA has confirmed that the Bexsero vaccine for menB used on the NHS should offer protection against the identified strain, and has published details of an initial genetic analysis for further research.
